519 related articles for article (PubMed ID: 24495045)
1. Binding and molecular dynamics studies of 7-hydroxycoumarin derivatives with human serum albumin and its pharmacological importance.
Yeggoni DP; Gokara M; Manidhar DM; Rachamallu A; Nakka S; Reddy CS; Subramanyam R
Mol Pharm; 2014 Apr; 11(4):1117-31. PubMed ID: 24495045
[TBL] [Abstract][Full Text] [Related]
2. Investigation of binding mechanism of novel 8-substituted coumarin derivatives with human serum albumin and α-1-glycoprotein.
Yeggoni DP; Manidhar DM; Suresh Reddy C; Subramanyam R
J Biomol Struct Dyn; 2016 Sep; 34(9):2023-36. PubMed ID: 26440860
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and α-1-acid glycoprotein.
Yeggoni DP; Rachamallu A; Kallubai M; Subramanyam R
J Biomol Struct Dyn; 2015; 33(6):1336-51. PubMed ID: 25054206
[TBL] [Abstract][Full Text] [Related]
4. Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein.
Gokara M; Kimavath GB; Podile AR; Subramanyam R
J Biomol Struct Dyn; 2015; 33(1):196-210. PubMed ID: 24359035
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the binding mechanism of asiatic acid with human serum albumin and its biological implications.
Gokara M; Malavath T; Kalangi SK; Reddana P; Subramanyam R
J Biomol Struct Dyn; 2014; 32(8):1290-302. PubMed ID: 23844909
[TBL] [Abstract][Full Text] [Related]
6. Comparative binding mechanism of lupeol compounds with plasma proteins and its pharmacological importance.
Kallubai M; Rachamallu A; Yeggoni DP; Subramanyam R
Mol Biosyst; 2015 Apr; 11(4):1172-83. PubMed ID: 25710711
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of the binding mechanism of coumarin derivatives with human serum albumin.
Garg A; Manidhar DM; Gokara M; Malleda C; Suresh Reddy C; Subramanyam R
PLoS One; 2013; 8(5):e63805. PubMed ID: 23724004
[TBL] [Abstract][Full Text] [Related]
8. Binding studies of L-3,4-dihydroxyphenylalanine with human serum albumin.
Yeggoni DP; Subramanyam R
Mol Biosyst; 2014 Dec; 10(12):3101-10. PubMed ID: 25209359
[TBL] [Abstract][Full Text] [Related]
9. Protein stability, conformational change and binding mechanism of human serum albumin upon binding of embelin and its role in disease control.
Yeggoni DP; Rachamallu A; Subramanyam R
J Photochem Photobiol B; 2016 Jul; 160():248-59. PubMed ID: 27130964
[TBL] [Abstract][Full Text] [Related]
10. Comparative binding studies of bacosine with human serum albumin and α-1-acid glycoprotein biophysical evaluation and computational approach.
Yeggoni DP; Rachamallu A; Subramanyam R
J Pharm Biomed Anal; 2022 Feb; 209():114478. PubMed ID: 34894460
[TBL] [Abstract][Full Text] [Related]
11. Probing the interaction of a coumarin-di(2-picolyl)amine hybrid drug-like molecular entity with human serum albumin: Multiple spectroscopic and molecular modeling techniques.
Khan S; Zafar A; Naseem I
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Dec; 223():117330. PubMed ID: 31280128
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulation and binding studies of beta-sitosterol with human serum albumin and its biological relevance.
Sudhamalla B; Gokara M; Ahalawat N; Amooru DG; Subramanyam R
J Phys Chem B; 2010 Jul; 114(27):9054-62. PubMed ID: 20565066
[TBL] [Abstract][Full Text] [Related]
13. Underlying the mechanism of vancomycin and human serum albumin interaction: a biophysical study.
Wu J; Wei R; Wang H; Li T; Ren W
J Biochem Mol Toxicol; 2013 Oct; 27(10):463-70. PubMed ID: 23922228
[TBL] [Abstract][Full Text] [Related]
14. Interaction of coumarin triazole analogs to serum albumins: Spectroscopic analysis and molecular docking studies.
Sharma K; Yadav P; Sharma B; Pandey M; Awasthi SK
J Mol Recognit; 2020 Jun; 33(6):e2834. PubMed ID: 32017307
[TBL] [Abstract][Full Text] [Related]
15. Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking.
Kabir MZ; Feroz SR; Mukarram AK; Alias Z; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2016 Aug; 34(8):1693-704. PubMed ID: 26331959
[TBL] [Abstract][Full Text] [Related]
16. Probing the binding of 8-Acetyl-7-hydroxycoumarin to human serum albumin by spectroscopic methods and molecular modeling.
Li D; Ji B; Sun H
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jul; 73(1):35-40. PubMed ID: 19243988
[TBL] [Abstract][Full Text] [Related]
17. Study on the interaction of the epilepsy drug, zonisamide with human serum albumin (HSA) by spectroscopic and molecular docking techniques.
Shahabadi N; Khorshidi A; Moghadam NH
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Oct; 114():627-32. PubMed ID: 23811149
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding of an anticancer drug, lapatinib to human serum albumin.
Kabir MZ; Mukarram AK; Mohamad SB; Alias Z; Tayyab S
J Photochem Photobiol B; 2016 Jul; 160():229-39. PubMed ID: 27128364
[TBL] [Abstract][Full Text] [Related]
19. Is the Sudlow site I of human serum albumin more generous to adopt prospective anti-cancer bioorganic compound than that of bovine: A combined spectroscopic and docking simulation approach.
Joshi R; Jadhao M; Kumar H; Ghosh SK
Bioorg Chem; 2017 Dec; 75():332-346. PubMed ID: 29096094
[TBL] [Abstract][Full Text] [Related]
20. Interaction of anticancer reduced Schiff base coumarin derivatives with human serum albumin investigated by fluorescence quenching and molecular modeling.
Dömötör O; Tuccinardi T; Karcz D; Walsh M; Creaven BS; Enyedy EA
Bioorg Chem; 2014 Feb; 52():16-23. PubMed ID: 24291035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
